Date published: 2025-12-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

USP17L Activators

The Ubiquitin-Specific Protease 17-like (USP17L) family encompasses a group of deubiquitinating enzymes that play a crucial role in cellular regulation by mediating the removal of ubiquitin tags from specific substrate proteins. This deubiquitination process is fundamental to a variety of cellular functions, including cell cycle progression, signal transduction, and stress response mechanisms. By cleaving ubiquitin from substrates, USP17L enzymes facilitate the recycling of ubiquitin, prevent unwarranted proteasomal degradation of proteins, and modulate the functional state of these proteins. The activity of USP17L is therefore integral to the maintenance of protein homeostasis, influencing both the stability and activity of key regulatory proteins within various signaling pathways. This positions USP17L at the nexus of critical cellular processes, underscoring its importance in cellular dynamics and homeostasis.

Activation of USP17L enzymes is tightly regulated and can be mediated through several mechanisms, ensuring that deubiquitination occurs in a controlled manner. One primary mechanism involves post-translational modifications (PTMs) of the USP17L enzyme itself, such as phosphorylation, which can enhance its enzymatic activity or alter its specificity for substrates. Additionally, the interaction of USP17L with specific regulatory proteins can modulate its activity; such interactions may serve to recruit USP17L to particular cellular compartments or to specific substrate proteins, thereby facilitating targeted deubiquitination. Furthermore, changes in cellular conditions, such as stress signals or DNA damage, can trigger the upregulation of USP17L expression, enhancing its activity in response to cellular needs. This multilayered regulation of USP17L activity highlights the complex interplay between deubiquitinating enzymes and cellular signaling pathways, reflecting the sophisticated mechanisms cells employ to maintain equilibrium and respond to environmental cues. Through these mechanisms, the activation of USP17L contributes to the orchestration of cellular processes, ensuring the appropriate regulation of protein function and stability in response to the dynamic intracellular environment.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin raises intracellular cAMP levels, which can activate PKA. PKA phosphorylation can increase USP17L activity by facilitating its access to substrates involved in deubiquitination processes.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG inhibits several protein kinases, potentially reducing competitive inhibition on substrates of USP17L, thereby enhancing USP17L deubiquitination activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, which may enhance USP17L activity by modulating calcium-dependent signaling pathways involved in protein deubiquitination.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$285.00
$520.00
$1300.00
78
(4)

Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A; inhibition of these phosphatases can increase phosphorylation levels of proteins, which may indirectly enhance the substrate availability for USP17L.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that can modulate AKT signaling. Reduced AKT activity might decrease phosphorylation-dependent ubiquitination, indirectly increasing the substrate pool for USP17L.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

S1P engages with G-protein-coupled receptors to activate downstream signaling that can include deubiquitination processes, potentially enhancing USP17L activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin disrupts ER calcium storage, leading to increased cytosolic calcium concentration, which could promote USP17L activity by influencing calcium-sensitive deubiquitinating enzymes.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates PKC which may have downstream effects on deubiquitination processes, indirectly enhancing USP17L function.

Sodium Orthovanadate

13721-39-6sc-3540
sc-3540B
sc-3540A
5 g
10 g
50 g
$45.00
$56.00
$183.00
142
(4)

Sodium orthovanadate is a general inhibitor of tyrosine phosphatases, which could lead to increased tyrosine phosphorylation, potentially affecting protein interactions and stability, indirectly enhancing USP17L activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK can alter signaling cascades and stress responses, potentially increasing the activity of USP17L by modulating its substrate interactions.